374 related articles for article (PubMed ID: 9750242)
1. A semiparametric Bayesian approach to the random effects model.
Kleinman KP; Ibrahim JG
Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian framework for intent-to-treat analysis with missing data.
Kleinman KP; Ibrahim JG; Laird NM
Biometrics; 1998 Mar; 54(1):265-78. PubMed ID: 9544521
[TBL] [Abstract][Full Text] [Related]
3. Demystifying optimal dynamic treatment regimes.
Moodie EE; Richardson TS; Stephens DA
Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
[TBL] [Abstract][Full Text] [Related]
4. Evaluating surrogate markers of clinical outcome when measured with error.
Dafni UG; Tsiatis AA
Biometrics; 1998 Dec; 54(4):1445-62. PubMed ID: 9883544
[TBL] [Abstract][Full Text] [Related]
5. Modelling progression of CD4-lymphocyte count and its relationship to survival time.
De Gruttola V; Tu XM
Biometrics; 1994 Dec; 50(4):1003-14. PubMed ID: 7786983
[TBL] [Abstract][Full Text] [Related]
6. Skew-normal Bayesian nonlinear mixed-effects models with application to AIDS studies.
Huang Y; Dagne G
Stat Med; 2010 Oct; 29(23):2384-98. PubMed ID: 20603815
[TBL] [Abstract][Full Text] [Related]
7. Models for empirical Bayes estimators of longitudinal CD4 counts.
LaValley MP; DeGruttola V
Stat Med; 1996 Nov 15-30; 15(21-22):2289-305; discussion 2337-40. PubMed ID: 8931202
[TBL] [Abstract][Full Text] [Related]
8. Intention-to-treat analyses for incomplete repeated measures data.
Hogan JW; Laird NM
Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
[TBL] [Abstract][Full Text] [Related]
10. Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.
Huang Y; Dagne G; Wu L
Stat Med; 2011 Oct; 30(24):2930-46. PubMed ID: 21805486
[TBL] [Abstract][Full Text] [Related]
11. Empirical power for distribution-free tests of incomplete longitudinal data with applications to AIDS clinical trials.
Kuhn AM; DeMasi RA
J Biopharm Stat; 1999 Aug; 9(3):401-16. PubMed ID: 10473028
[TBL] [Abstract][Full Text] [Related]
12. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
[TBL] [Abstract][Full Text] [Related]
13. Analysis of relation between virologic responses and immunologic responses, patient's factors in AIDS clinical trials using a semiparametric mixed-effects model.
Liang H; Zou G
Biom J; 2007 Jun; 49(3):406-15. PubMed ID: 17623345
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
Wu L
Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
[TBL] [Abstract][Full Text] [Related]
15. Bayesian semiparametric zero-inflated Poisson model for longitudinal count data.
Dagne GA
Math Biosci; 2010 Apr; 224(2):126-30. PubMed ID: 20085773
[TBL] [Abstract][Full Text] [Related]
16. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
[TBL] [Abstract][Full Text] [Related]
17. Semiparametric Bayesian inference on skew-normal joint modeling of multivariate longitudinal and survival data.
Tang AM; Tang NS
Stat Med; 2015 Feb; 34(5):824-43. PubMed ID: 25404574
[TBL] [Abstract][Full Text] [Related]
18. Multiple augmentation for interval-censored data with measurement error.
Song X; Ma S
Stat Med; 2008 Jul; 27(16):3178-90. PubMed ID: 18040984
[TBL] [Abstract][Full Text] [Related]
19. An approximate generalized linear model with random effects for informative missing data.
Follmann D; Wu M
Biometrics; 1995 Mar; 51(1):151-68. PubMed ID: 7766771
[TBL] [Abstract][Full Text] [Related]
20. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
